IDDI

Patients

Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.

Oncology

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.